Quantitative Androgen Deficiency in the Aging Male (qADAM)

The qADAM is a quantitative questionnaire that scores the severity of androgen‑deficiency symptoms in aging men.

Rate your sex drive (libido)
Terrible+1Poor+2Average+3Good+4Excellent+5
Rate your energy level
Terrible+1Poor+2Average+3Good+4Excellent+5
Rate your strength/endurance
Terrible+1Poor+2Average+3Good+4Excellent+5
Rate your enjoyment of life
Terrible+1Poor+2Average+3Good+4Excellent+5
Rate your happiness level
Terrible+1Poor+2Average+3Good+4Excellent+5
How strong are your erections?
Terrible+1Poor+2Average+3Good+4Excellent+5
Rate your work performance over last 4 weeks
Terrible+1Poor+2Average+3Good+4Excellent+5
How often do you fall asleep after dinner?
Never+11-2 times per week+23-4 times per week+35-6 times per week+4Every Night+5
Rate your sports ability over last 4 weeks
Terrible+1Poor+2Average+3Good+4Excellent+5
How much height have you lost
2 inches or more+11.5 - 1.9 inches+21.0 - 1.4 inches+30.5 - 0.9 inches+40.4 inches or less+5

Indications d'utilisation

Used to screen men ≥50 with symptoms suggesting androgen deficiency (low libido, ED, low energy) before biochemical testing. Offers high sensitivity but poor specificity, so results only guide who needs serum testosterone testing, not diagnosis. Clinical utility is limited: in a cohort of 5028 men, qADAM showed AUC 0.529 for detecting low free T 1 [Level II evidence], meaning positive screens require laboratory confirmation.

Informations et précautions

Use only as a screening symptom score, not a diagnostic tool. It shows high sensitivity but poor specificity, leading to many false positives (e.g., weak correlation with testosterone levels in validation work 1 [Level II evidence]). Symptoms overlap with depression, chronic disease, and medication effects, so biochemical testing remains essential. Do not use the score to initiate testosterone therapy, as treatment decisions require unequivocally low morning testosterone plus compatible clinical features.